Long-term suppression of atrial fibrillation by botulinum toxin injection into epicardial fat pads in patients undergoing cardiac surgery: Three-year follow-up of a randomized study

Botulinum toxin (BTX) injections into epicardial fat pads in patients undergoing coronary artery bypass grafting (CABG) has resulted in suppression of atrial fibrillation (AF) during the early postoperative period through 1-year of follow-up in a pilot program.

Source: Heart Rhythm - November 6, 2018 Category: Cardiology Authors: Alexander Romanov, Evgeny Pokushalov, Dmitry Ponomarev, Sevda Bayramova, Vitaliy Shabanov, Denis Losik, Ilya Stenin, Dmitry Elesin, Igor Mikheenko, Artem Strelnikov, David Sergeevichev, Boris Kozlov, Sunny S. Po, Jonathan S. Steinberg Source Type: research